MIRA INFORM REPORT

 

 

Report No. :

314642

Report Date :

03.04.2015

 

IDENTIFICATION DETAILS

 

Name :

HAMELN RDS GMBH

 

 

Registered Office :

Langes Feld 13, D 31789 Hameln

 

 

Country :

Germany

 

 

Financials (as on) :

31.12.2013

 

 

Date of Incorporation :

14.05.2004

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

·         Manufacture of basic pharmaceutical products

·         Wholesale of pharmaceutical goods

·         Other research and experimental development on natural sciences and engineering

 

 

No. of Employees :

42

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

Germany

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

GERMANY - ECONOMIC OVERVIEW

 

The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, has contributed to strong growth and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 5.3% in 2013. The new German government introduced a minimum wage of $11 per hour to take effect in 2015. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's total budget deficit - including federal, state, and municipal - to 4.1% in 2010, but slower spending and higher tax revenues reduced the deficit to 0.8% in 2011 and in 2012 Germany reached a budget surplus of 0.1%. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016 though the target was already reached in 2012. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela MERKEL announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its electricity generating capacity and 46% of its base-load electricity production.

 

Source : CIA

 

 

Company name & address

 

HAMELN RDS GMBH

 

 Company Status:                     active

                                                Langes Feld 13

                                                D 31789 Hameln

                                                Telephone:05151/581-0

                                                Telefax:  05151/581-258

                                                Homepage: www.hameln-pharma.de

                                                 E-mail:   welcome@hameln-pharma.com

 

 VAT no.:                                  DE814202993

 

 

CONCLUSION

 

 Business relations are permissible.

 

 LEGAL FORM           Private limited company

 Date of foundation:  14.05.2004

 Shareholders'

 agreement:           14.05.2004

 Registered on:       25.11.2004

 Commercial Register: Local court 30175 Hannover

 under:               HRB 102041

 

 Share capital:                          EUR             30,000.00

 

 Shareholder:

                      Siegfried Deutschland Holding GmbH

                      Wallbrunnstr. 24

                      D 79539 Lörrach

                      Legal form: Private limited company

                      Share capital:     EUR          1,789,521.58

                      Share:             EUR             30,000.00

                      Registered on: 20.08.2001

                      Reg. data: 79098 Freiburg, HRB 630912

 Manager:

                      Torsten Foerster

                      D 58135 Hagen

                      having sole power of representation

                      born: 30.03.1965

 Proxy:

                      Jens Huter

                      D 31789 Hameln

                      authorized to jointly represent the company

                      born: 14.07.1969

 Proxy:

                      Dr. Christian Liek

                      D 31860 Emmerthal

                      authorized to jointly represent the company

                      born: 29.11.1973

 Proxy:

                      Olaf Wegener

                      D 31848 Bad Münder

                      authorized to jointly represent the company

                      born: 09.02.1965

 

 Further functions/participations of Torsten Foerster (Manager)

 Manager:

                      hameln pharmaceuticals gmbh.

                      Langes Feld 13

                      D 31789 Hameln

                      Legal form: Private limited company

                      Share capital:     EUR            750,000.00

                      Registered

                      on:         07.09.1959

                      Reg. data:  30175 Hannover, HRB 100015

 

 

COMPANY HISTORY

 

 14.05.2004 - 25.11.2004  Epsilon Fünfundzwanzigste

                          Vermögensverwaltungs GmbH

                          Lüerstr. 10-12

                          D 30175 Hannover

                          Private limited company

 25.11.2004 - 23.04.2007  hameln pharma r & d gmbh

                          Langes Feld 13

                          D 31789 Hameln

                          Private limited company

 

 

RESIGNED ACTING PERSONS AND SHAREHOLDERS

 

 31.07.2012 - 07.01.2015  Manager

                          Wolf-Christian Kanzelmeyer

                          D 31789 Hameln

 11.01.2011 - 23.07.2012  Manager

                          Christoph Kerstein

                          D 31787 Hameln

 

 

BUSINESS ACTIVITIES

 

 Main industrial sector

 2110    Manufacture of basic pharmaceutical products

46461   Wholesale of pharmaceutical goods

72190   Other research and experimental development on natural sciences and engineering

 

 Secondary industrial sector

 6420    Activities of holding companies

 

Foreign participation:

 

 -hameln rds, a.s. in Modra, Slovakia

 

 Payment experience:  within agreed terms

 

 Negative information: We have no negative information at hand.

 

 

REAL ESTATE

 

 Type of ownership:   Tenant

 Address              Langes Feld 13

                      D 31789 Hameln

 

 Land register documents were not available.

 

 

BANKERS

 

 A bank connection is unknown.

 

 

FINANCIAL FIGURES

 

 Gross profit or loss:2013           EUR          4,613,592.00

 Profit:              2013                  EUR            103,877.00

 Ac/ts receivable:                       EUR          2,073,932.00

 Liabilities:                                 EUR          8,389,777.00

 Employees:                                                     42

 

 

BALANCE SHEETS

 

 Balance sheet ratios 01.01.2013 - 31.12.2013

 Equity ratio [%]:                 67.88

 Liquidity ratio:                   0.92

 Return on total capital [%]:       1.14

 

 Balance sheet ratios 01.01.2012 - 31.12.2012

 Equity ratio [%]:                  0.40

 Liquidity ratio:                   0.20

 Return on total capital [%]:       3.54

 

 EQUITY RATIO

 The equity ratio indicates the portion of the equity as compared

 to the total capital. The higher the equity ratio, the better the

 economic stability (solvency) and thus the financial autonomy of

 a company.

 

 LIQUIDITY RATIO

 The liquidity ratio shows the proportion between adjusted

 receivables and net liabilities. The higher the ratio, the lower

 the company's financial dependancy from external creditors.

 

 RETURN ON TOTAL CAPITAL

 The return on total capital shows the efficiency and return on

 the total capital employed in the company. The higher the return

 on total capital, the more economically does the company work

 with the invested capital.

 

Type of balance sheet:               Company balance sheet

 

 Financial year:      01.01.2013 - 31.12.2013

 

 ASSETS                                  EUR          9,099,278.34

  Fixed assets                           EUR          5,928,627.00

   Tangible assets                       EUR             28,560.00

   Financial assets                      EUR          5,900,067.00

    Other / unspecified financial assets EUR          5,900,067.00

  Current assets                         EUR          3,169,651.34

   Stocks                                EUR          1,094,401.73

   Accounts receivable                   EUR          2,073,931.81

    Amounts due from related companies   EUR            400,659.20

    Other debtors and assets             EUR          1,673,272.61

   Liquid means                          EUR              1,317.80

  Difference assets / liabilities        EUR              1,000.00

 

 LIABILITIES                             EUR          9,099,278.34

  Shareholders' equity                   EUR             40,401.57

   Capital                               EUR             30,000.00

    Subscribed capital (share capital)   EUR             30,000.00

   Reserves                              EUR              4,429.89

    Capital reserves                     EUR              4,429.89

   Balance sheet profit/loss (+/-)       EUR              5,971.68

    Balance sheet profit / loss          EUR              5,971.68

  Provisions                             EUR            669,100.00

  Liabilities                            EUR          8,389,776.77

   Financial debts                       EUR             83,215.05

    Liabilities due to banks             EUR             83,215.05

   Other liabilities                     EUR          8,306,561.72

    Liabililties due to related companiesEUR          7,085,781.71

    Unspecified other liabilities        EUR          1,220,780.01

 

 PROFIT AND LOSS ACCOUNT (cost-summary method) according to Comm.

 Code (HGB)

  Gross result (+/-)                     EUR          4,613,592.36

  Staff expenses                         EUR          1,940,005.98

   Wages and salaries                    EUR          1,653,012.09

   Social security contributions and

   expenses for pension plans and

   benefits                              EUR            286,993.89

  Total depreciation                     EUR             11,644.11

   Depreciation on tangible / intangible

   asssets (incl. start-up and exp. of

   bus.                                  EUR             11,644.11

  Other operating expenses               EUR          2,170,883.44

  Operating result from continuing

  operations                             EUR            491,058.83

  Interest result (+/-)                  EUR           -386,291.65

   Interest and similar income           EUR                 63.16

   Interest and similar expenses         EUR            386,354.81

  Financial result (+/-)                 EUR           -386,291.65

  Result from ordinary operations (+/-)  EUR            104,767.18

  Expenses for transfer of profits to a

  parent company                         EUR            103,695.18

  Other taxes / refund of taxes          EUR               -890.00

  Tax (+/-)                              EUR               -890.00

  Annual surplus / annual deficit        EUR                182.00

 

 Type of balance

 sheet:               Company balance sheet

 

 Financial year:      01.01.2012 - 31.12.2012

 

 ASSETS                                  EUR         10,023,850.39

  Fixed assets                           EUR          5,940,271.11

   Tangible assets                       EUR             40,204.11

   Financial assets                      EUR          5,900,067.00

    Other / unspecified financial assets EUR          5,900,067.00

  Current assets                         EUR          4,083,579.28

   Stocks                                EUR          2,134,955.51

   Accounts receivable                   EUR          1,947,106.47

    Amounts due from related companies   EUR            365,813.20

    Other debtors and assets             EUR          1,581,293.27

   Liquid means                          EUR              1,517.30

 

 LIABILITIES                             EUR         10,023,850.39

  Shareholders' equity                   EUR             40,401.57

   Capital                               EUR             30,000.00

    Subscribed capital (share capital)   EUR             30,000.00

   Reserves                              EUR              4,429.89

    Capital reserves                     EUR              4,429.89

   Balance sheet profit/loss (+/-)       EUR              5,971.68

    Balance sheet profit / loss          EUR              5,971.68

  Provisions                             EUR            228,000.00

  Liabilities                            EUR          9,755,488.82

   Financial debts                       EUR             70,623.60

    Liabilities due to banks             EUR             70,623.60

   Other liabilities                     EUR          9,684,865.22

    Liabililties due to related companiesEUR          7,479,245.28

    Unspecified other liabilities        EUR          2,205,619.94

  Difference assets / liabilities        EUR                -40.00

 

 PROFIT AND LOSS ACCOUNT (cost-summary method) according to Comm.

 Code (HGB)

  Gross result (+/-)                     EUR          4,661,338.15

  Staff expenses                         EUR          1,989,961.90

   Wages and salaries                    EUR          1,694,916.92

   Social security contributions and

   expenses for pension plans and

   benefits                              EUR            295,044.98

  Total depreciation                     EUR             18,549.54

   Depreciation on tangible / intangible

   asssets (incl. start-up and exp. of

   bus.                                  EUR             18,549.54

  Other operating expenses               EUR          1,871,456.38

  Operating result from continuing

  operations                             EUR            781,370.33

  Interest result (+/-)                  EUR           -425,254.77

   Interest and similar income           EUR                  0.11

   Interest and similar expenses         EUR            425,254.88

  Financial result (+/-)                 EUR           -425,254.77

  Result from ordinary operations (+/-)  EUR            356,115.56

  Expenses for transfer of profits to a

  parent company                         EUR            354,921.56

  Other taxes / refund of taxes          EUR             -1,194.00

  Tax (+/-)                              EUR             -1,194.00

  Annual surplus / annual deficit        EUR                  0.00

 

 Inconsistent balance sheets:

 Financial year                              published on

 01.01.2011 - 31.12.2011                     14.02.2013

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.59

UK Pound

1

Rs.92.46

Euro

1

Rs.67.51

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAR

 

 

Report Prepared by :

TPT

 

               


 

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.